Cite

HARVARD Citation

    Pan, B. et al. (2018). Recipient-derived IL-22 alleviates murine acute graft-versus-host disease in association with reduced activation of antigen presenting cells. Cytokine. pp. 33-40. [Online]. 
  
Back to record